Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Havlickuv Brod

8 clinical trials in Havlickuv Brod, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Havlickuv Brod at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Havlickuv Brod

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Cardiac failure

Recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Roflumilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Havlickuv Brod

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical research focusing on atherosclerotic cardiovascular disease treatment evaluation, specifically testing new therapeutic approaches for patients whose current lipid-modifying therapies need enhancement.

  • Cardiovascular event prevention
  • Arterial plaque management
  • Advanced lipid therapy

Studies include assessment of major cardiovascular events and coronary interventions.

02 Pulmonary Medicine

Comprehensive research into Chronic Obstructive Pulmonary Disease, evaluating new treatment combinations and therapeutic approaches for moderate to severe cases.

  • COPD exacerbation management
  • Triple therapy optimization
  • Long-term treatment safety

Multiple trials focusing on reducing exacerbation rates and improving patient outcomes.

03 Heart Failure Studies

Advanced research examining novel combination therapies for heart failure, with particular focus on treatments for patients with specific ejection fraction parameters.

  • Combination therapy evaluation
  • Cardiovascular mortality reduction
  • Heart failure hospitalization prevention

Trials aim to improve outcomes in heart failure management through innovative therapeutic combinations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.